Latest filing published 11 Jul 2011 for ARADIGM CORP, €1.4M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
First Eagle Value in Biotechnology Master Fund, Ltd.: trading record in brief
First Eagle Value in Biotechnology Master Fund, Ltd. is a declared insider of Aradigm Corp, with filings sourced from SEC (Form 4). Between 9 December 2009 and 7 July 2011, the trades on record add up to 5 filings.
On the market, this insider has only ever bought: 2 purchases, €3.3M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. In 2011 alone, the filings show 1 purchase and no sales.
On 11 July 2011 came the latest disclosure, an open-market purchase for €1.4M in Aradigm Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to First Eagle Value in Biotechnology Master Fund, Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,625,000 shares@ US$0.19Common StockSEC:0001457518-11-000001:0Canonical exit: 5 Oct 2011 (T+90)
- 4,215,239 shares@ US$0.1184Common StockSEC:0001457518-10-000006:0
- 19,433,408 shares@ US$0.1184Common StockSEC:0001457518-10-000002:0Canonical exit: 16 Sept 2010 (T+90)
- 5,153,517 shares0Common StockSEC:0000919574-09-016755:0
- 5,153,517 shares0Common StockSEC:0000919574-09-016755:1
5 of 5 declarations